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The transition to menopause is a major hormonal event, 
associated with physical and psychosocial symptoms, and 
which may cause adverse changes in women’s quality of 
life. Empirical and epidemiological studies demonstrate 
that endogenous estradiol concentration drops sharply after 
menopause. Changes in circulating hormone levels during 
menopause are associated with cognitive, physiological and 
gross motor performance difficulties and affect the emo-
tional well-being of women. Estradiol effects on brain mor-
phology are the following: higher levels of estradiol which 
inhibit the cell loss in the later life of postmenopausal wom-
en (Hogervorst, Williams, Budge, Ridel, & Jolles, 2000), a 
decrease of the effect of oxidative stress after brain trauma 
and the enhancement of the number of surviving neurons in 
the hippocampus (Behl, 1999). Beyond its impacts on direct 
neurophysiological pathways, estradiol affects brain mor-
phology through lipid metabolical mechanisms. Reduction 
in circulating estrogen after menopause is accompanied by 
the changes in plasma levels of cholesterol and its fractions 
(Bittner, 2002). In menopause adverse changes in lipopro-
tein profiles occur, including the increase in total choles-
terol (TC) and LDL cholesterol and decreases in HDL (Bit-
tner, 2002). Cross-sectional studies consistently show more 
adverse lipoprotein patterns among postmenopausal than 
among premenopausal women (Bittner, 2002). 
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Decline in cognitive performance and changes in metabolism are characteristics of aging. The increased level 
of LDL in serum is associated with a higher risk to atherosclerosis that causes minor and major decline in cogni-
tive functioning. On the other hand, HDL levels are associated with better preserved cognitive functioning in older 
age. The aim of the present study is to assess the association between levels of total serum cholesterol (TC), LDL, 
and HDL, as well as perceptual-motor, verbal, visuospatial and executive cognitive functions, and perception of 
menopausal state of health of menopausal women. A sample of 52 postmenopausal women was recruited from an 
outpatient gynecology clinic. The following measures and parameters were used: analysis of serum total LDL, and 
HDL cholesterol; standard neuropsychological testing of cognitive performance in perceptual- motor, verbal, visu-
ospatial and executive domains, assessment of the perception of menopausal state of health. The results showed that 
perceptual motor speed was the highest at medium TC level. Higher TC and LDL levels were related to the reduction 
of verbal memory performance. The higher level of HDL was associated with increased working memory perform-
ance. Women with lower level of TC and LDL reported more health complaints occurring in menopause, while the 
highest level of HDL was related to the best perception of somatic state. These data demonstrate that verbal memory 
decline is associated with elevated levels of TC and LDL, and support the protective effects of increased plasma 
HDL in maintaining cognitive functions.
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Almost a quarter of the unesterified cholesterol present 
in the human body is contained in the brain, but whether be-
havior and cognitive functioning are affected by serum lipid 
levels is not clearly understood yet. Cholesterol is required 
for the formation and maintenance of cell membrane perme-
ability and fluidity. In the brain, unesterified cholesterol is 
present in large quantities in the plasma membranes of glial 
and neuronal cells, and in the specialized membranes of my-
elin (Reiss, Keith, Rahman, Chan, Ghiso, & de Leon 2004). 
Recycling cholesterol in the brain, through esterification and 
utilizing apoE and LDL receptor transport may be important 
for neuron repair and growth (Dietschy & Turley, 2001). 
Longstanding hypercholesterolemia may lead to weaken-
ing of endothelial functions in cerebrovascular arterioles 
and capillaries and these changes may impair brain me-
tabolism (Levine, Keaney, & Vita, 1995). Lipid/lipoprotein 
abnormalities have been implicated in the pathogenesis of 
ischemic cerebrovascular disease (CVD) (Demchuk, Hess, 
Brass, & Yatsu, 1999), but results are often contradictory 
regarding the predictive effect of serum cholesterol on the 
total stroke risk (Prospective Studies, Lancet, 1995). On the 
other hand, HDL proved to be a protective factor to athero-
sclerotic changes and CVD (Reiss et al., 2004). In a popu-
lation based case-control study (Sacco, Benson, Kargman, 
Boden-Albala, Tuck, & Lin, 2001), increased HDL levels 
were associated with the reduced risk for ischemic stroke 
in the elderly. HDL plays a central role in the removal of 
cholesterol from cells, and in reversing cholesterol transport 
from the peripheral tissue to the liver (Reiss et al., 2004). 
The status of the vascular system largely depends on 
the rate of lipoprotein (cholesterol, LDL, HDL) metabolism 
dysfunction and the progression of atherosclerosis. It also 
plays a pivotal role in the cognitive decline associated with 
atherosclerosis. A number of studies report that serum li-
poprotein levels may be important predictors of cognitive 
functioning in aging. However, data demonstrating that 
dyslipidemia is associated with a higher risk of cognitive 
impairment are conflicting. Recent studies have shown el-
evated plasma concentrations of 24-hydroxycholesterol in 
patients with Alzheimer’s disease (AD) and vascular de-
mentia (Reiss et al., 2004), but other studies had the op-
posite results in the severe stage of AD (Papassotiropoulos, 
Lüthjohann, Bagli, Locatelli, Jessen, & Rao, 2000). Non-
pathological late-life cognitive performance was not found 
to be related to blood lipid levels (Teunissen et al., 2003). 
Researches of age-related cognitive disorders, dementia and 
the vascular risk factors for cognitive impairment, increas-
ingly focus attention on the role of cholesterol metabolism 
in the pathogenesis of these diseases. 
Researches considering the contribution of serum lipo-
protein levels to cognitive function in aging have yielded 
inconclusive results. Differences in data may reflect the 
varieties in the diagnostic criteria of cognitive impairment, 
methods and domains of cognitive testing, and the different 
duration of follow-up. 
The Framingham Heart Study (Elias, Elias, D’Agostino, 
Sullivan, & Wolf, 2005) found significant positive linear 
associations between biennially assessed TC, and the 4 to 
6 years’ follow-up assessment of cognitive functioning of 
verbal fluency, attention/concentration, abstract reasoning, 
and composite scores in all the measured domains. Lower 
endogenous TC level (<200mg/dL) was related to poorer 
performance on cognitive measures. In an undergraduate 
sample Benton (1995) reported slower speed of mental 
processing and reaction times shown with lower level of TC 
in a choice decision task. Among monozygotic twin pairs 
persons with lower level of baseline TC exhibited percep-
tual-motor and visual attention performance level decline 
on the WAIS Digit Symbol Substitution Test over a 5-year 
period relative to the twins with higher baseline TC level 
(Swan, LaRue, Carmelli, Reed, & Fabsitz, 1992). Cognitive 
test performance on WAIS subscales reflecting crystallized 
intelligence (Information; Vocabulary Subscales) varied 
inversely with TC and LDL. Achievement on trials assess-
ing fluid intelligence (Block Design) was the poorest at the 
lowest TC level and improved with an increasing level of 
TC (age = 41.7 y) (Muldoon, Ryan, Matthews, & Manuck, 
1997.) Elevation in TC levels was found to be associated 
with better memory performance in healthy middle-aged 
women (Henderson, Guthrie, & Dennerstein, 2003).
Postmenopausal women in the highest LDL cholesterol 
quartile of the sample showed worse performance in Mini-
Mental State Examination scores than participants belong-
ing to the lowest quartile. Reduction in the LDL cholesterol 
level during 4 years tended to be related with lower odds of 
impairment. HDL cholesterol was not associated with cog-
nition (Yaffe, Barrett-Connor, Lin, & Grady, 2002). Serum 
levels of cholesterol precursors (lathosterol and lanosterol) 
correlated negatively with performance on the Word Learn-
ing Test for verbal learning and memory both, in baseline 
tests and over the 6-year follow-up period, independent 
from age, education and sex (Teunissen et al., 2003). Plasma 
levels of HDL cholesterol, which declines in aging, had pos-
itive linear association with Mini Mental State Examination 
scores in centenarians (Ma, Muzumdar, Gabriely, Atzmon, 
& Barzilai, 2003). A large population-based study (Kivi-
pelto et al., 2001) evaluating the impact of midlife vascu-
lar risk factors (elevated serum cholesterol level and blood 
pressure) on the subsequent development of mild cognitive 
impairment (MCI) in elderly found that midlife elevated 
cholesterol level (≥ 6.5 mmol/L) was a significant risk fac-
tor for MCI. In conclusion, results from previous studies 
are controversial due to methodological differences and 
variations in examined age cohorts. Further conflicting data 
may be derived from differing psychosocial factors, namely 
mood and psychological well-being that presumably impose 
impact on cognitive performance. 
Naturally occurring low cholesterol levels have been re-
lated to increased depression (Wardle, 1995; Brown, Salive, 
Harris, Simonsick, Guralnick, & Kohout, 1994; Horsten, 
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Wamala, Vingerhoest, Orth-Gomer, & 1997; Suarez, 1999), 
anxiety (Suarez, 1999) and lower levels of social support 
(Horsten et al., 1997) across different age groups (van Dam, 
Schiut, Schouten, Vader, & Pop, 1999). Results are inconsist-
ent regarding gender differences and general health. Chen, 
Lu, Wu, and Chang (2001) reported that in a large nonclini-
cal sample of women, low level of HDL-C (<35 mg/dL) was 
linked with heightened psychological distress manifest in 
depression, somatization, phobic anxiety, interpersonal sen-
sitivity and hostile aggression, while TC levels below 160 
mg/dL showed negative correlation to anxiety, and hostility. 
The reduction of lipid level through drug therapy was ac-
companied by increased depression in men (Beigel, Peleg, 
Assali, & Nachson, 1998). In obese women the relationship 
between lower TC level and negative mood was found to be 
age-specific and limited to the elderly (<60 years) (Troisi 
et al., 2001). Depression may have a biological link to low 
cholesterol by its association with altered central serotoner-
gic function (Steegmans et al., 1996)
Relatively few studies have focused solely on menopau-
sal and postmenopausal women (Dealberto, Ducimetiere, 
Mainard, & Alperovitch, 1993; Horsten et al., 1997; Brown, 
Giggey, Dennis, & Waldstein, 2004). Affective symptoms 
may occur during times of hormonal changes such as meno-
pause. Decreased central serotonergic functioning has been 
related to the drop in estrogen during menopause (Meltzer, 
1989) and may in part account for the increase of depression 
in this cohort. Besides the consequence of hormonal attenu-
ation, menopause brings the challenge of accommodation to 
complex changes in family roles, partnership and life cycle, 
which may cause mood oscillations as well. Increased de-
pressive symptoms were found among women with low cho-
lesterol levels (<4.7 mmol/l) even after their adjustment to 
the menopausal status (Horsten et al., 1997). More frequent 
depressive symptoms were associated with lower cholesterol 
level among women not taking HRT (Brown et al., 2004). 
The potential effect of changing lipid profiles during 
menopause on cognitive performance and psychological 
well-being are supported by several studies. Elevated lipid 
levels proved to be risk factors not only because of adverse 
cardiovascular and atherosclerotic processes, but through 
vascular damage, for cognitive impairments. In order to 
preserve physical and mental health in aging it is advisable 
to control the lipid levels, but to date it is not clear which 
domains of cognitive functioning are most influenced by 
cholesterol. In addition lipid lowering prevention trials in-
crease the risk of negative mood, i.e. depression and anxiety 
(Wardle, 1995). Consequently, setting the optimal choles-
terol level after menopause is important for the preservation 
of mental health including both psychological well-being 
and the prevention of cognitive decline. 
The purpose of the present study was to explore the 
effect of serum total, LDL and HDL cholesterol levels to 
different domains of cognitive performance and emotional 
well-being in postmenopausal women. The study inves-
tigated which cognitive domains are the most vulnerable 
to fluctuation serum lipid levels in order to investigate 
the possible areas of prevention for cognitive impairment 
in aging. It was hypothesized that increased levels of total 
cholesterol and LDL cholesterol support perceptual-motor 
and visuospatial functions and link with lower depression 
and anxiety, and are associated with verbal memory and the 
decline of executive functions. In addition, increased HDL 




52 volunteer postmenopausal women (age: 51.96 ± 5.78 
years, range 42-66) participated in the study (see Table 1). 
They were recruited from an outpatient gynecology clinic. 
The participants had reached menopause at the mean of 8.63 
Table 1
Descriptive statistics of the sample with total serum cholesterol, HDL cholesterol and LDL cholesterol
M SD Min Max Low Medium High
Age 51.96 5.78 42 66
Education 13.98 2.80 8 18 1-8 year 9-12 year 13-18 year
BMI 26.72 3.73 21 39
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± 2.31 years before entering the study (range: 1 to 15). Six 
of the 52 participants (11%) reached menopause because of 
uterectomy in the age between 41 and 59 (mean age during 
the time of the study was 54.16±5.95 years, range 45-61). 
The uterectomysed group differed neither in their mean age 
(t(50) = 1.29; n.s.), nor in the time of the last menstruation 
(39.5 ± 24.96 vs. 40.68 ± 47.03 months; t(45) = 0.52; n.s.) 
from women who reached menopause naturally. None of the 
women were currently on hormonal replacement therapy. 
Years of formal education ranged from primary school to 
university level (13.98 ± 2.80 ranges 8-18). Mean BMI was 
26.72 ± 3.73, range 21-39. 
Women with current occurrence or past history of psy-
chiatric and neurological disorders, cardiovascular, renal or 
hepatic diseases were excluded from the study. The local 
Committee of Medical Ethics approved to the study proto-
col. All participants provided written informed consent. 
Procedure and Instruments
Lipid analyzes. Fasting blood sample for lipid analyzes 
was collected in the medical laboratory of the outpatient 
clinic. HDL, LDL, and cholesterol from serum were defined 
by a standard method (in mmol/l).
Assessment of cognitive functions and mood. Partici-
pants were screened for demographic, health, and life style 
information. Cognitive performance measure and mood, 
emotional and menopausal symptom assessment was ac-
complished in two settings for 7 days consecutively.
Assessment of cognitive functions
Cognitive functioning was assessed by standard neu-
ropsychological tests in four domains: (a) perceptual–motor 
functions (perceptual-motor speed and visuospatial atten-
tion); (b) visuospatial short term memory; (c) verbal abili-
ties: fluency, short term and working memory and learning; 
and (d) executive functions. 
Perceptual motor functions:
Trail making Test Part A, B (Reitan & Wolfson, 1985; 
Mitrushina, Boone, & D’ Elia, 1995.). Part A contains a 
page with scattered circled numbers from 1 to 25, and par-
ticipants are instructed to connect the numbers with lines in 
ascending order as quickly as possible. Part B is a page with 
circled numbers from 1 to 13 and letters from A to L. Partic-
ipants are instructed to connect the numbers and letters with 
lines in order, alternating between numbers and letters. The 
Trail Making Test assesses attention, visual scanning, and 
the speed of eye-hand coordination, as well as information 
processing. In addition, Part B assesses an executive func-
tion, the ability to alternate between sets of stimuli. The two 
obtained scores reflect the total time in seconds needed to 
complete each task. Reliability coefficients vary consider-
ably, with most of them above 0.60, but several in the 0.80.
s (see Lezak, 2004). 
Wechsler Symbol Digit Subtest (Weschler, 1939). In this 
WAIS subtest, participants are requested to copy symbols 
marked by numbers into cells that are indexed with num-
bers. Time limit is 90s. The Symbol Digit test measures the 
speed of eye-hand coordination and information processing, 
as well as selective attention. We used raw scores that re-
flect the number of correctly copied symbols. Psychometric 
properties of the Hungarian version of the WAIS proved to 
be good (see: Kun & Szegedi, 1996). 
Rey-Osterreith Complex Figure Test – drawing and 3 
minutes delayed recall (Rey, 1941; Lezak, 2004). Rey Os-
terreith Complex Figure test is composed of a complex fig-
ure constructed from 18 simple geometrical shapes (lines, 
rectangles, triangles, circles). First, participants are instruct-
ed to copy the figure as precisely as possible, and to recall 
and draw it 3 minutes later as precisely as they can. The 
test assesses the graphomotor coordination and visuospatial 
memory. Interscorer reliability for the Rey-figure tends to 
be high- above .95 (see Lezak, 2004). 
Verbal functions:
Addenbrook’s verbal fluency test (Hungarian version, 
Stachó, Ivándy, & Dudás, 2001): letter and category fluency. 
In this verbal fluency task participants are asked to list as 
many words as they can: a) beginning with a certain letter; 
and b) belonging to a semantic category (names of animals) 
in 1 minute time. Psychometric properties and internal con-
sistency of the Addenbrook’s test proved to be good (Cron-
bach-alpha is .78; Mathuranath, Nestor, Berrios, Rakowitz, 
& Hodges, 2000).
Wechsler Digit Span subtest (Wechsler, 1939). Digit 
Span (DS) has two subtests assessing immediate recall of 
numerical lists forward or backward. Forward recall assess-
es short-term memory capacity, backward recall measures 
working memory capacity (Wechsler, 1939). Psychometric 
properties of the Hungarian version of the WAIS proved to 
be good (see: Kun & Szegedi, 1996).
AVLT - Rey Auditory Verbal Learning Test (Rey, 1941; 
Mitrushina et al., 1995). AVLT has been extensively used to 
evaluate the ability to acquire and retain new verbal infor-
mation. The test assesses serial learning using 15 common 
nouns. It provides a simple measure of immediate recall, 
assesses learning over successive trials, and identifies in-
correct memory mechanisms caused by interference and 
confabulation. The administration procedure includes five 
successive presentations of the original list of 15 nouns fol-
lowed by free recall on each trial; a following interference 
trial involving the presentation and free recall of another list 
of 15 words; a post interference free recall of the original 
list; and a 30 minutes delayed free recall of the original list. 
The AVLT has good reliability scores (see Lezak, 2004). We 
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used three categories to measure performance: (I) TOT- to-
tal number of recalled words in each list (I.-VII.); (II) PE- 
number of perseverative errors, when the participant recalls 
the same word repeatedly (this type of error represents a 
tendency to perseverate, which is a fine deficit of self-moni-
toring mechanisms.); and (III) CO - number of correctly re-
called words. 
Executive functions:
WCST Wisconsin Card Sorting Test (Grant & Berg, 
1948). WCST was originally developed to assess abstract 
reasoning ability and the ability to shift cognitive strate-
gies in response to changing environmental contingencies. 
Thus it is considered as a measure of executive functions 
(Heaton, Chelune, Talley, Kay, & Curtiss, 1993). WTSC 
requires organized searching, strategic planning, utilizing 
environmental feedback to shift cognitive sets, flexible 
responding and modulating impulsive responding. These 
cognitive functions are major elements of executive func-
tions and working memory (Tranel, Anderson, & Benton, 
1994). Participants have to deduce a rule for sorting cards, 
which can be sorted by color, shape, or number, and have 
to switch between sorting rules, based on feedback of cor-
rect or incorrect response. Performance on WCST is re-
lated to the physiological activation of the dorsolateral 
prefrontal cortex that is involved in the control of central 
executive functions and working memory (Berman et al., 
1995). Cronbach-alpha coefficients for WCST subscores 
are moderately good, ranging from .53 to .72 (Heaton et 
al., 1993). 
Emotional and menopausal symptom assessment  
questionnaires:
Women’s Health Questionnaire (Hunter, 1992). WHQ 
is a 37 item questionnaire providing a rapid assessment of 
several separate domains of physical and emotional func-
tioning of middle-aged women. Responses are recorded 
on a four point Likert-scale. WHQ contains 9 subscales: 
depression (WHQ-D), somatization (WHQ-S, memory 
(WHQ-M), vasomotor symptoms (WHQ-V), anxiety 
(WHQ-A), sex problems (WHQ-Sex), sleeping problems 
(WHQ-Sleep), menstrual problems (WHQ-Mens.), attrac-
tivity subscales (WHQ-Att.). The psychometric properties 
of the WHQ are being computed using a large data base. 
Provisional multi-trait analysis suggests that the internal 
reliability of the subscales is reasonably good. Cronbach 
alpha levels were as follows: depressed mood (.7), anxiety 
(.77), somatic symptoms (.76), vasomotor symptoms (.84), 
sleep problems (.73); for menstrual problems and sexual 
problems the coefficients were lower, being .64 and .59 re-
spectively (Hunter, 2003.)
RESULTS
Findings of neuropsychological and symptom  
assessment in connection with cholesterol level
ANOVA showed no differences in age (F(2, 30) = 1.30; 
n.s.) and educational level (F(2, 86) = 1.86; n.s.) among the 
groups of women in the high, medium, and low cholesterol 
tertiles. Assessment of cognitive functioning in the percep-
tual-motor domain revealed significant difference only in 
WAIS Symbol Digit scores (shown in Table 2). A conducted 
Tukey post hoc test indicated higher perceptual-motor speed 
in Symbol Digit coding in the medium cholesterol level ter-
tile compared to the low cholesterol level tertile Trail mak-
ing test performance showed no other differences between 
different cholesterol level groups. 
As can be seen from Table 2 and Figure 1, the analysis 
of AVLT records confirmed a significant decrease in AVLT 
trials II, III, IV, V, delayed recall in trial VII, and the total 
number of recalled words from all trials (AVLT ∑TOT) in 
the high cholesterol level group. Verbal learning capacity 
(AVLT II.-V.) and verbal retention reflected in the delayed 
recall (AVLT VII.) were poorer in the high cholesterol level 
group. Perseverative tendencies showed a significant corre-
lation with the medium level of TC. Participants in the me-
dium cholesterol level tertile made more perseverative error 
than participants belonging to the low and high tertiles of 
cholesterol levels. Verbal learning capacity measured by the 
number of correctly recalled words proved to be increased 
in the group of medium cholesterol level tertile compared to 
the group of high levels of serum cholesterol. In the delayed 
condition, participants in the medium cholesterol level 
group also recalled more correct words (AVLT CO VII). 
Women with medium levels of cholesterol reported 
more expressed somatic and sleeping complaints (shown in 
Table 2) than participants with lower and higher cholesterol 
levels. Participants who had either lower or higher levels 
of cholesterol, considered their health-related quality of life 
to be better in terms of somatic, menopausal and sleeping 
complaints.
Findings of neuropsychological and symptom  
assessment in connection with low-density lipoprotein
ANOVA revealed that individuals with high level of 
LDL showed reduced verbal learning capacity performance 
in the AVLT trial IV and recalled fewer words correctly in 
AVLT trials IV and VI compared to participants with me-
dium or low level of LDL (see Table 3).
Low levels LDL was associated with poorer perform-
ance in the rule abstraction (Learning to Learn) subtests of 
WCST. Post hoc test revealed that in the measures of ab-
stract reasoning participants in the medium tertile differed 
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Table 2
Results of cognitive assessment and m enopausal symptom assessment in relation to serum cholesterol levels 
Low Medium High Statistics
M SD M SD M SD F df p Tukey
Trail-Making A (sec) 129.0 36 102.0 42 127.5 38 1.66 2 n.s
Trail-Making B (sec) 50.64 25 51.59 20 50.35 18 0.02 2 n.s
WAIS Symbol Digit 50.8 8.88 62.0 10.09 54.6 8.27 6.36 2 <.05 l-m
Rey-Osterreith recall 15.80 6.2 15.26 5.4 13.68 7.2 0.66 2 n.s.
AVLT Total sum 84.25 12.20 94.70 9.43 74.11 15.27 11.46 2 <.05 m-h
AVLT Pers. Err. sum 6.93 3.85 12.35 5.97 5.47 4.21 9.69 2 <.05 l-mm-h
AVLT Cor. Res. sum 71.87 9.99 78.70 8.66 67.47 14.31 4.28 2 <.05 m-h
WHQ-Depression 0.31 0.42 0.29 0.12 0.36 0.25 0.36 2 n.s.
WHQ-Somatization 0.36 0.28 0.47 0.45 0.44 0.29 0.60 2 n.s.
WHQ-S15 0.46 0.51 0.88 0.34 0.56 0.51 3.28 2 <.05 m-h
WHQ-Sleep29 0.77 0.43 0.20 0.41 0.40 0.50 2.61 2 <.05 l-m
WHQ-Memory 0.55 0.48 0.54 0.36 0.68 0.42 0.63 2 n.s
WHQ- Vasomotor 0.53 0.35 0.56 0.47 0.65 0.51 0.27 2 n.s.
WHQ-Anxiety 0.40 0.23 0.39 0.27 0.43 0.36 0.11 2 n.s.
WHQ-Sex 0.48 0.32 0.47 0.33 0.60 0.49 0.33 2 n.s.
WHQ-Menopausal 0.15 0.08 0.31 0.15 0.23 0.10 2.01 2 n.s.
Note. AVLT Total sum: the total number of all recalled words form list. I. to VII. Of the Auditory Verbal Learning Test; AVLT Pers. Err.sum: the total number 
of all perseverative repetitions form list. I. to VII. of the Auditory Verbal Learning Test; AVLT Corr. Res. Sum: the total number of all correctly recalled 
words form list. I. to VII. of the Auditory Verbal Learning Test; WHQ-S15: item 15th of the somatization subscale of the WHQ; WHQ-Sleep29: item 
29th of the sleep problems subscale of the WHQ.
Tukey-test: l-low levels of cholesterol; m-medium level of cholesterol; h-high level of cholesterol; l-m: significant difference between low and medium level 
groups. 
Figure 1. Verbal learning performance measured by AVLT in relation to serum cholesterol levels
Note. AVLT Total III.:the number of all recalled words form list. III. of the Auditory Verbal Learning Test; AVLT Total IV.: the number of all recalled words 
form list. IV. of the Auditory Verbal Learning Test; AVLT Total V.: the number of all recalled words form list. V. of the Auditory Verbal Learning Test; 
AVLT Total VII.: the number of all recalled words form list. VII. of the Auditory Verbal Learning Test. 
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Table 3
Result of cognitive assessment and menopausal symptom assessment in relation to serum LDL levels
Low Medium High Statistics
M SD M SD M SD F df p Tukey
AVLT total words IV 12.82 2.53 13.82 1.55 11.53 3.08 3.68 2 < .05 m-h
AVLT cor. words IV 11.47 1.87 11.76 1.25 10.23 1.85 3.94 2 <.05 m-h
AVLT cor. words VI 10.11 2.11 10.64 2.54 7.76 2.90 1.66 2 <.05 l-hm-h
WISC Learning to Learn -15.74 13.64 -5.06 8.89 -7.50 11.03 3.61 2 <.05 l-m
WHQ-V27 0.71 0.46 0.27 0.45 0.63 0.50 3.65 2 <.05 l-m
WHQ-Mens. sum 0.33 0.23 0.08 0.13 0.32 0.23 6.86 2 <.05 m-h
Note. AVLT Total words IV.: the total number of all recalled words from list. IV. of the Auditory Verbal Learning Test.; AVLT Corr. Words IV.: the total 
number of all correctly recalled words form list. IV. of the Auditory Verbal Learning Test.; AVLT Corr. Words Vi.: the total number of all correctly re-
called words form list. VI. of the Auditory Verbal Learning Test.; WISC Learning to Learn: the Learning to Learn subscores of the WISC.; WHQ-V27: 
item 27th of the vasomotor subscale of the WHQ.; WHQ-Mens. Sum: summarized scores of menopausal symptoms of the menstrual problems subscale 
of the WHQ.
Tukey-test: l- low levels of LDL; m-medium level of LDL; h-high level of LDL; l-m: significant difference between low and medium level groups. 
Table 4
Results of cognitive assessment and menopausal symptom assessment in relation to serum HDL levels
Low Medium High Statistics
M SD M SD M SD F df p Tukey
Educational level 13.69 2.02 12.65 2.29 15.18 1.59 6.16 2 <.05 m-h
Trail Making A (sec) 139 10.5 116 18.2 102 15.9 2.41 2 n.s.
Trail Making B (sec) 52.67 9.9 48.29 11.2 51.94 15.5 0.27 2 n.s.
WAIS Symbol Digit 57.53 8.2 55.76 7.6 55.0 9.2 0.25 2 n.s.
Rey-Osterreith recall 14.88 8.2 13.56 8.45 16.28 7.6 1.03 2 n.s.
WAIS Digit Span fw 6.44 0.85 5.76 0.68 6.29 0.08 1.62 2 n.s
WAIS Digit Span bw 4.56 0.81 3.88 0.78 4.59 0.79 4.25 2 <.05 m-h
WAIS Digit Span sum 11.00 0.76 9.65 0.89 10.88 0.91 3.31 2 n.s.
Verbal Fluency summa 12.25 0.65 11.76 0.72 12.29 0.74 0.74 2 n.s.
WHQ-Depression 0.40 0.54 0.32 0.29 0.26 0.45 1.27 2 n.s.
WHQ-Somatization 0.54 0.22 0.45 0.29 0.31 0.23 3.10 2 <.05 l-h
WHQ-S35 0.67 0.49 0.53 0.51 0.25 0.44 4.48 2 <.05 l-m-h
WHQ Sleep 0.60 0.42 0.52 0.49 0.47 0.33 0.48 2 n.s.
WHQ-Memory 0.64 0.29 0.58 0.32 0.57 0.44 0.15 2 n.s.
WHQ- Vasomotor 0.65 0.35 0.59 0.39 0.53 0.42 0.25 2 n.s
WHQ-Anxiety 0.50 0.42 0.40 0.35 0.34 0.31 1.10 2 n.s.
WHQ-Sex 0.64 0.42 0.48 0.35 0.45 0.27 0.47 2 n.s
WHQ-Menopausal 0.17 0.05 0.24 0.19 0.28 0.18 0.81 2 n.s.
Note. WAIS Digit Span fw: row scores of WAIS Digit Span forward trial; WAIS Digit Span bw: row scores of WAIS Digit Span backward trial; WAIS Digit 
Span sum: sum of row scores of WAIS Digit Span forward and backward trial; WHQ-S35: item 35th of the somatization subscale of the WHQ.
Tukey-test: l- low levels of HDL; m-medium level of HDL; h-high level of HDL; l-m: significant difference between low and medium level groups. 
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significantly from participants with low level of LDL. No 
other differences on WCST variables were found among 
high, medium, and low level of LDL groups. 
Fewer vasomotor complaints (WHQ-27) were reported 
in the group of medium level of LDL compared to the low 
level group. Women belonging to either groups of high or 
low levels of LDL experience more menopausal symptoms 
on WHQ-Mens scale, than participants in the medium level 
range.
Findings of neuropsychological and symptom assess-
ment in connection with high-density lipoprotein
The results of ANOVA computed on neuropsychologi-
cal test scores indicated significant difference only in WAIS 
Digit Span Backward between HDL groups (Table 4). A post 
hoc test revealed that participants with increased HDL level 
showed significantly better working memory performance 
measured by WAIS Digit Span raw score than individuals 
with medium HDL level. To ascertain that educational level 
differences between the medium and high cholesterol level 
tertile had no confounding effect on the association of HDL 
levels with working memory performance, we conducted 
ANOVA on WAIS scores among groups of different edu-
cational levels. Results showed no relation of educational 
level to WAIS results (F(2,30) = 2.26; n.s.). Women in the 
low HLD cholesterol level tertile reported in the WHQ So-
matisation Scale expressed more somatic symptoms accom-
panying menopause than individuals in the high level tertile 
(see Table 4).
DISCUSSION
In the present study of postmenopausal women, the vari-
eties of effects of total, LDL and HDL cholesterol on differ-
ent domains of cognitive performance and emotional well-
being were shown. In accordance with our expectations, and 
consistent with previous studies (Swan et al., 1992; Benton, 
1995), our results demonstrated a declination in fine percep-
tual-motor skills, graphomotor speed and visual attention 
measured by WAIS Symbol Digit Subtest, in the group with 
the lowest level of total cholesterol. The group with medi-
um level of TC performed better in the WAIS Symbol Digit 
Subtest than the group with low levels of TC, as reflected in 
higher speed of visual information processing and reaction 
times. These results are in accordance with the findings of 
Benton (1995) and Swan (1992). However, lipoprotein frac-
tion had no impact on visuospatial memory performance. 
 One of the most significant findings presented here in-
dicate that high levels of serum TC and LDL cholesterol are 
related to exhibited verbal memory problems. The adverse 
effect of the increased TC and LDL on verbal learning ca-
pacity and retention appeared in both immediate and delayed 
recall performances. Compared to LDL a stronger effect of 
TC on verbal memory performance was experienced. The 
present results tend to corroborate the findings of Teunissen 
et al. (2003) who reported a negative correlation of serum 
levels of cholesterol precursors (lathosterol and lanosterol) 
with verbal learning and memory in both, baseline tests and 
over the 6-year follow-up period, but our results were con-
sistent with other studies (Reitz, Luschinger, Tang, Manly, 
& Mayeux, 2005). 
A detailed analysis of verbal learning performance re-
flecting the ratio of perseverative errors, correct responses 
and total recall showed that better achievement in the group 
of medium TC and LDL level compared to high level groups. 
This means a quantitative, not a qualitative enhancement of 
verbal learning capacity, because both, the number of cor-
rect responses and of perseverative errors, increased at low-
er serum lipid levels. 
An opposite impact of HDL was found on working 
memory; and the highest level of HDL was associated with 
the improved working memory performance. Our finding, 
that higher levels of HDL strengthen a basic cognitive func-
tion, i.e. working memory, confirmed evidences that sup-
port the beneficial effects of elevated level of HDL on the 
cognitive performance in aging (Ma et al., 2003; Atzmon, 
Gabriely, Greiner, Davidson, Schechter, & Barzilai, 2002). 
The protective influence of HDL to atherosclerotic changes 
(Reiss et al., 2004) may play an important role in the preser-
vation of frontal lobe mediated executive functions, such as 
working memory in aging. 
The analysis of the results of higher executive function 
test WCST revealed that rule abstraction scores (Learning 
to Learn) increased in the group with a medium level of 
LDL compared to the low level groups. Learning to Learn 
scores show the extent of participant’s ability to recognize 
and maintain the general rule of sorting across consecutive 
categories (Heaton et al., 1993). This result is in accord-
ance with previous findings about the association of lower 
cholesterol level with reduced executive functions in terms 
of speed of mental processing and attention concentration 
(Benton, 1995; Yaffe et al., 2002; Elias et al., 2005). How-
ever, because of the calculation method of Learning to Learn 
scores, this result should be interpreted with caution. 
There are conflicting data showing that dyslipidemia is 
related to a higher risk of cognitive impairment (Kivipelto et 
al., 2001; Yaffe et al., 2002; Teunissen et al., 2003). Results 
in this study are inconsistent with a set of previous stud-
ies (Reitz et al., 2005), that found zero or negative associa-
tion between TC, LDL and cognitive performance (Elias et 
al., 2005; Henderson et al., 2003; Swan et al., 1992). These 
contradictions may arise from differences in methodology, 
varieties of methods and the different domains of cognitive 
functioning, the mean age of the sample, and the duration 
of follow up. Studies finding negative association between 
cognitive performance and serum lipoprotein level seemed 
to have failed to make the differentiation of lipoprotein frac-
tions of cholesterol, LDL and HDL and measured only TC 
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level and assessed different areas of cognition (Elias et al., 
2005; Henderson et al., 2003; Muldoon et al., 1997), which 
may explain conflicting results. Previous researches that 
measured TC LDL and HDL separately and assessed verbal 
memory found either the lack of association between lev-
els of plasma lipids and verbal memory (Reitz et al., 2005; 
Teunissen et al., 2003;), or results similar to our findings 
(Muldoon et al., 2000). 
Our present findings suggest that reduced level of TC 
and LDL have different effects on different cognitive func-
tions; low TC and LDL mildly impair perceptual-motor and 
executive functions but support the preservation of verbal 
memory performance. These apparent contradictions may 
have biological plausibility. Neuronal cells require cho-
lesterol for normal metabolic processes (Muldoon, Flory, 
& Ryan, 2001), for the microviscosity of cell membranes 
and signal transduction (Golier, Marzuk, Leon, Weiner, & 
Tardiff, 1995). The interaction between plasma cholesterol 
concentrations, cholesterol present in the cell membrane, 
and serotonergic activity is complex and may account for 
negative cognitive effects of low cholesterol level. The rela-
tionship between low serum cholesterol concentrations and 
impulsive behavior (Manuck, Flory, McCaffery, Matthews, 
Mann, & Muldoon, 1998) has turned attention towards the 
role of cholesterol in serotonin metabolism (Steegmans et. 
al, 1996) and it is possible that adverse modulating effect 
of low TC on serotonergic activity may extend to the role 
of serotonin in cognitive processes as well. Serotonin dys-
regulation may have an impact on the adverse modulation of 
prefrontal lobe mediated response selection and inhibitory 
processes (Clark, Cools, & Robbins, 2004) which are the 
key components in graphomotor coordination, and visual 
attention measured by WAIS Digit Symbols Substitution 
Subtest and executive function assessed by WISC. 
The assessment of life satisfaction and state of health 
demonstrated that there is no relationship between the sense 
of life satisfaction, general health perception and serum lip-
id profiles. Contrary to our expectation, the present findings 
did not confirm the association of negative emotionality (i.e. 
elevated anxiety and depression scores) with decreased level 
of cholesterol and LDL. The possible explanations may be 
derived from the relatively good health and socioeconomic 
condition of the present sample, and from the lack of direct 
assessment of mood. 
Detailed assessment of women’s perceived health state 
indicated that participants who had the lowest levels of TC 
and LDL reported the most somatic complaints reflected 
in the number of vasomotor menopausal symptoms and 
sleeping disorders, while individuals with high level of 
HDL reported the best physical state - an important factor 
of well-being. Because negative affectivity, in terms of de-
pression and anxiety, is often accompanied y somatization 
and focusing on somatic signs (Van Diest, De Peuter, Ee-
rtmans, Bogaerts, Victoir, & Van den Bergh, 2005; Costa 
& McCrae, 1987; Watson & Pennebaker, 1989), and the 
link between low levels of TC and LDL to negative mood 
states is well established (Wardle, 1995; Chen et al., 2001), 
a more precise assessment of mood would have been neces-
sary to evaluate the mediating pathways between the sharp-
ened perceived health complaints and lipoprotein levels in 
the present sample. In relation to the present findings it is 
presumable that beyond psychological effects of mood on 
health state perception, lipoprotein fractions directly influ-
ence women’s somatic state through atherosclerotic proc-
esses. Previous research confirmed the protective role of 
HDL in atherosclerotic changes. Consequently, women with 
high levels of HDL are supposed to have better condition of 
health than those with low level of HDL. 
Although attempts of lowering lipid levels intend to 
reduce risk factors for cognitive impairments (Yaffe et al., 
2002) findings in the present sample concerning the percep-
tual-motor and executive function decline and the negative 
perception of health state show the possibility of beneficial 
and possibly adverse effects of low serum TC and LDL lev-
els. Decreased TC and LDL may impair executive functions 
by their relation to impulsivity and inhibitory problems, and 
through their relation with serotonergic dysregulation could 
increase the risk for negative mood. 
The limitation of the present study was the relatively 
small sample size, which was further divided along the 
cholesterol tertiles and has diminished statistical power. 
A detailed analysis of mood and psychological well-being 
would have made it possible to examine the multiple effects 
of TC LDL and HDL levels, mood and cognitive perform-
ance. Hopefully, the results and limitations of the present 
study will be taken into consideration in further researches 
designed to elucidate the mechanisms underlying the rela-
tionships between serum lipoprotein levels and cognitive 
performance, as well as psychological well-being in post-
menopausal women. 
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